77 Active Studies

Iron Deficiency Anemia Clinical Trials Near You

Find 77 actively recruiting iron deficiency anemia research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

77Active Trials
82+Locations
17,327Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Iron Deficiency Anemia Clinical Trials

Iron Deficiency Anemia clinical trials are recruiting across 82 cities. Here are the cities with the most active studies:

Iron Deficiency Anemia Trial Phases

NA(52 studies)
PHASE3(8 studies)
PHASE2(6 studies)
PHASE4(4 studies)
PHASE1(2 studies)

56 research organizations are sponsoring iron deficiency anemia trials.

About Iron Deficiency Anemia

Iron deficiency anemia is the most common type of anemia worldwide, occurring when the body lacks sufficient iron to produce adequate hemoglobin. It causes fatigue, weakness, and pale skin. Treatment includes iron supplementation and addressing the underlying cause of iron loss.

Clinical trials are advancing new treatments for iron deficiency anemia. Currently, 77 studies are recruiting a combined 17,327 participants across the United States. Research is being conducted by 56 organizations including Cynthia Fontanella, New York University, Ohio State University and 53 others.

2026 Iron Deficiency Anemia Research Landscape

As of July 2026, the iron deficiency anemia clinical trial landscape includes 77 actively recruiting studies across 82 cities in the United States. These studies are collectively seeking 17,327 participants, with an average enrollment target of 225 per study.

The research spans multiple phases of development: 52 studies are in NA, 8 studies are in PHASE3, 6 studies are in PHASE2, 4 studies are in PHASE4, 2 studies are in PHASE1. The presence of Phase 3 trials indicates that some iron deficiency anemia treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 56 different organizations, including Cynthia Fontanella, New York University, Ohio State University, Children's Hospital Medical Center, Cincinnati, David Chu, and 51 others. The large number of sponsors reflects significant research interest and investment in iron deficiency anemia treatment advancement.

Geographically, iron deficiency anemia trials are most concentrated in Los Angeles, California (8 trials); Chicago, Illinois (8 trials); Birmingham, Alabama (6 trials); Ann Arbor, Michigan (6 trials); Boston, Massachusetts (5 trials) and 7 other cities.

Featured Iron Deficiency Anemia Studies

Highlighted recruiting studies for iron deficiency anemia, selected by enrollment size and research scope.

RecruitingNCT06018285 · NA

Stepped Approach to Reducing Risk of Suicide in Primary Care

Suicide is the second leading cause of death among young people aged 12-17 years in the United States, yet many youth at risk for suicide are not identified or go untreated. Stepped care approaches have been shown to be effective at reducing suicide risk in clinical settings, including primary care. The goal of this hybrid I stepped wedge effectiveness-implementation study is to test the effective...

Sponsor: Cynthia Fontanella· 2,572 participants· 10 locations (Akron, Ashtabula, Athens, Columbus)
View full study details →
RecruitingNCT05654207 · NA

WeCare: A System of Care for Black Youth

The overall goal of this study is to respond to the urgent need for an effective suicide prevention strategy for Black youth by examining the effectiveness of a systems-level strategy to recognize and respond to suicide risk among Black adolescents who present to emergency departments (EDs). The proposed strategy, WeCare, combines combines three components: (1) universal screening using the Comput...

Sponsor: New York University· 2,200 participants· 1 location (New York)
View full study details →
RecruitingNCT06094218 · NA

Development of a Treatment Prognosis Calculator for the Prevention of Suicide

The goal of this interventional study is to develop and test a treatment prognosis calculator to identify which service members with suicidal ideation or behavior are likely to respond well to the current standard of care treatment and which should instead receive Brief Cognitive Behavioral Therapy (BCBT) as a first-line treatment. The main aims of the study are: * Aim 1: To develop a novel trea...

Sponsor: Ohio State University· 1,200 participants· 1 location (Columbus)
View full study details →

Frequently Asked Questions About Iron Deficiency Anemia Clinical Trials

Are there iron deficiency anemia clinical trials near me?

Yes, there are 77 iron deficiency anemia clinical trials currently recruiting across 82+ cities in the United States, including Los Angeles, California; Chicago, Illinois; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.

How do I join a iron deficiency anemia clinical trial?

To join a iron deficiency anemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are iron deficiency anemia clinical trials free?

Yes, participation in iron deficiency anemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of iron deficiency anemia treatments are being studied?

Current iron deficiency anemia clinical trials are testing a range of approaches across NA (52 studies), PHASE3 (8 studies), PHASE2 (6 studies), PHASE4 (4 studies), PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 56 research organizations.

Is it safe to participate in iron deficiency anemia clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated July 16, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov